The results of network analysis revealed that TF was also the core target in the PPI network, and it had a close relationship with most core targets of CX in the treatment of thrombosis, such as ALB, VEGFA, TNF, PTGS2, ICAM1, VCAM1, etc. Therefore, TF might also be a central target of CX when treating thrombosis. The gene discussed is VCAM1; the disease is deep vein thrombosis.